Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03732950
Title Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA / Jonsson Comprehensive Cancer Center Los Angeles California 90095 United States Details
University of Minnesota/Masonic Cancer Center Minneapolis Minnesota 55455 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field